Cargando…
Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment
Lipid metabolic alterations are associated with cancer progression. Lysine-specific demethylase 1 (LSD1) plays a crucial role in cancer and has become a promising target for cancer therapy. However, the effect of LSD1 on lipid metabolism remains unclear. In the present study, we used a LC-MS/MS-base...
Autores principales: | Li, Yan, Qian, Xinying, Lin, Yiyun, Tao, Lei, Zuo, Zeping, Zhang, Huaqin, Yang, Shengyong, Cen, Xiaobo, Zhao, Yinglan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444191/ https://www.ncbi.nlm.nih.gov/pubmed/34498714 http://dx.doi.org/10.3892/or.2021.8184 |
Ejemplares similares
-
Synergistic antitumor effect of 5-fluorouracil with the novel LSD1
inhibitor ZY0511 in colorectal cancer
por: Peng, Wen, et al.
Publicado: (2020) -
The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy
por: Liu, Huan, et al.
Publicado: (2021) -
Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells
por: Gong, Jin, et al.
Publicado: (2020) -
Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B
por: Sang, Na, et al.
Publicado: (2023) -
Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51
por: Tao, Lei, et al.
Publicado: (2023)